{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:26:32Z","timestamp":1792092392186,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejrad.2021.110017","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T12:19:08Z","timestamp":1635941948000},"page":"110017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Integrated Positron Emission Tomography\/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2021.110017_b0005","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement. 17(3) (2021) 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"10.1016\/j.ejrad.2021.110017_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/386527","article-title":"Pleiotropic protective effects of phytochemicals in Alzheimer's disease","volume":"2012","author":"Davinelli","year":"2012","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.ejrad.2021.110017_b0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","article-title":"Update on Alzheimer's Disease Therapy and Prevention Strategies","volume":"68","author":"Graham","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jalz.2013.01.015","article-title":"Implications of early treatment among Medicaid patients with Alzheimer's disease","volume":"10","author":"Geldmacher","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ejrad.2021.110017_b0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnagi.2016.00304","article-title":"Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America","volume":"8","author":"Cardona-G\u00f3mez","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.ejrad.2021.110017_b0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/brain\/awu393","article-title":"Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly","volume":"138","author":"Vemuri","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0971-6203.54844","article-title":"Advances in multimodality molecular imaging","volume":"34","author":"Zaidi","year":"2009","journal-title":"J. Med. Phys."},{"key":"10.1016\/j.ejrad.2021.110017_b0040","article-title":"Advances in PET\/MR instrumentation and image reconstruction","author":"Cabello","year":"2016","journal-title":"Br. J. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2021.110017_b0045","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","article-title":"Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease","volume":"68","author":"Devanand","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejrad.2021.110017_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nicl.2017.04.001","article-title":"Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study","volume":"15","author":"Ramos","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0055","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.neuroimage.2012.01.075","article-title":"MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease","volume":"60","author":"Devanand","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.05.018","article-title":"Structural MRI changes detectable up to ten years before clinical Alzheimer's disease","volume":"33","author":"Tondelli","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejrad.2021.110017_b0065","doi-asserted-by":"crossref","DOI":"10.1177\/1971400917697342","article-title":"Resting state fMRI: A review on methods in resting state connectivity analysis and resting state networks","author":"Smitha","year":"2017","journal-title":"Neuroradiol. J."},{"issue":"7","key":"10.1016\/j.ejrad.2021.110017_b0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1017\/S1041610216000429","article-title":"Regional functional synchronizations in dementia with Lewy bodies and Alzheimer's disease","volume":"28","author":"Peraza","year":"2016","journal-title":"Int. Psychogeriatr."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.neuroimage.2011.08.049","article-title":"Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity","volume":"59","author":"Zhang","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejrad.2021.110017_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-clinpsy-032511-143049","article-title":"Default mode network activity and connectivity in psychopathology","volume":"8","author":"Whitfield-Gabrieli","year":"2012","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"8","key":"10.1016\/j.ejrad.2021.110017_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/brain.2014.0234","article-title":"Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairment","volume":"4","author":"Weiler","year":"2014","journal-title":"Brain Connect."},{"issue":"52","key":"10.1016\/j.ejrad.2021.110017_b0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001734","article-title":"APOE Polymorphism Affects Brain Default Mode Network in Healthy Young Adults: A STROBE Article","volume":"94","author":"Su","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejrad.2021.110017_b0095","doi-asserted-by":"crossref","first-page":"14824","DOI":"10.1038\/srep14824","article-title":"Aberrant intra- and inter-network connectivity architectures in Alzheimer's disease and mild cognitive impairment","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2021.110017_b0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.archger.2015.09.010","article-title":"Default mode network connectivity is linked to cognitive functioning and CSF A\u03b21-42 levels in Alzheimer's disease","volume":"62","author":"Celebi","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hbm.22213","article-title":"Amyloid and its association with default network integrity in Alzheimer's disease","volume":"35","author":"Adriaanse","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"18","key":"10.1016\/j.ejrad.2021.110017_b0110","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1523\/JNEUROSCI.0141-08.2008","article-title":"Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease","volume":"28","author":"He","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1148\/radiol.12120928","article-title":"Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity","volume":"267","author":"Binnewijzend","year":"2013","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.ejrad.2021.110017_b0120","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00330-015-3652-0","article-title":"Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients","volume":"25","author":"Verclytte","year":"2015","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00330-015-3789-x","article-title":"Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI","volume":"26","author":"Steketee","year":"2016","journal-title":"Eur. Radiol."},{"issue":"10","key":"10.1016\/j.ejrad.2021.110017_b0130","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00330-015-3696-1","article-title":"Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin","volume":"25","author":"Verfaillie","year":"2015","journal-title":"Eur. Radiol."},{"issue":"22","key":"10.1016\/j.ejrad.2021.110017_b0135","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1212\/WNL.0b013e31823a0ef7","article-title":"Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease","volume":"77","author":"Chen","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1258\/ar.2011.110272","article-title":"The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images","volume":"53","author":"Fu","year":"2012","journal-title":"Acta Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13760-013-0197-3","article-title":"Diffusion tensor imaging (DTI) in the detection of white matter lesions in patients with mild cognitive impairment (MCI)","volume":"113","author":"Sali","year":"2013","journal-title":"Acta Neurol. Belg."},{"issue":"50","key":"10.1016\/j.ejrad.2021.110017_b0150","doi-asserted-by":"crossref","first-page":"16876","DOI":"10.1523\/JNEUROSCI.4136-10.2010","article-title":"Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer's disease","volume":"30","author":"Lo","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejrad.2021.110017_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pscychresns.2017.04.004","article-title":"Automated detection of pathologic white matter alterations in Alzheimer's disease using combined diffusivity and kurtosis method","volume":"264","author":"Chen","year":"2017","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.crad.2016.11.002","article-title":"Clinical application of apparent diffusion coefficient mapping in voxel-based morphometry in the diagnosis of Alzheimer's disease","volume":"72","author":"Takahashi","year":"2017","journal-title":"Clin. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1148\/radiol.12112361","article-title":"Disrupted topological organization in white matter structural networks in amnestic mild cognitive impairment: relationship to subtype","volume":"265","author":"Shu","year":"2012","journal-title":"Radiology"},{"issue":"49","key":"10.1016\/j.ejrad.2021.110017_b0170","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1523\/JNEUROSCI.2027-14.2014","article-title":"Early Alzheimer's disease neuropathology detected by proton MR spectroscopy","volume":"34","author":"Murray","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000341604","article-title":"An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease","volume":"2","author":"Gordon","year":"2012","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"issue":"5","key":"10.1016\/j.ejrad.2021.110017_b0180","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/mrm.21951","article-title":"Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease","volume":"61","author":"Chamberlain","year":"2009","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3988\/jcn.2009.5.4.153","article-title":"Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies","volume":"5","author":"Mistur","year":"2009","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","article-title":"Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease","volume":"70","author":"Protas","year":"2013","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2967\/jnumed.111.096578","article-title":"Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature","volume":"53","author":"Bohnen","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-2012-121489","article-title":"Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients","volume":"33","author":"Choo","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1254\/jphs.11R08FM","article-title":"Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET\/SPECT imaging probes for diagnosis of Alzheimer's disease","volume":"118","author":"Ono","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.ejrad.2021.110017_b0210","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s00330-013-3005-9","article-title":"The common dementias: a pictorial review","volume":"23","author":"Bhogal","year":"2013","journal-title":"Eur. Radiol."},{"issue":"8","key":"10.1016\/j.ejrad.2021.110017_b0215","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.0000000000001877","article-title":"Amyloid-\u03b2 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejrad.2021.110017_b0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.apradiso.2015.07.003","article-title":"Synthesis optimization of 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB), \u03b2-amyloid PET imaging tracer for Alzheimer's disease diagnosis","volume":"105","author":"Coliva","year":"2015","journal-title":"Appl. Radiat. Isot."},{"issue":"Suppl. 3","key":"10.1016\/j.ejrad.2021.110017_b0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer's prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejrad.2021.110017_b0230","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","article-title":"Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD","volume":"77","author":"Rabinovici","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ejrad.2021.110017_b0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnmol.2017.00343","article-title":"PET\/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias","volume":"10","author":"Zhang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.ejrad.2021.110017_b0240","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.ejrad.2021.110017_b0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.ejrad.2021.110017_b0250","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00259-014-2728-4","article-title":"Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects","volume":"41","author":"Nemmi","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.ejrad.2021.110017_b0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.ejrad.2021.110017_b0260","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2967\/jnumed.115.158774","article-title":"Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images","volume":"56","author":"Carbonell","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"issue":"10043","key":"10.1016\/j.ejrad.2021.110017_b0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejrad.2021.110017_b0275","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1038\/ncomms10759","article-title":"Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease","volume":"7","author":"Sehlin","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0280","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-2011-110659","article-title":"Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease","volume":"26","author":"Blazquez-Llorca","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"Pt 6","key":"10.1016\/j.ejrad.2021.110017_b0290","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/brain\/awu064","article-title":"Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET","volume":"137","author":"Okamura","year":"2014","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ejrad.2021.110017_b0295","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","article-title":"[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease","volume":"42","author":"Harada","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.ejrad.2021.110017_b0300","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"issue":"Pt 5","key":"10.1016\/j.ejrad.2021.110017_b0305","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ejrad.2021.110017_b0310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marqui\u00e9","year":"2015","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.ejrad.2021.110017_b0315","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.0b013e31828970c2","article-title":"Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease","volume":"80","author":"Ewers","year":"2013","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.ejrad.2021.110017_b0320","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nnano.2014.254","article-title":"Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease","volume":"10","author":"Viola","year":"2015","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.ejrad.2021.110017_b0330","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2967\/jnumed.109.073908","article-title":"Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications","volume":"51","author":"Kwee","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110017_b0335","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/RLU.0b013e318266ce52","article-title":"Combined use of 18F-FDG PET\/CT, DW-MRI, and DCE-MRI in treatment response for preoperative chemoradiation therapy in locally invasive rectal cancers","volume":"38","author":"Gu","year":"2013","journal-title":"Clin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.ejrad.2021.110017_b0345","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1088\/0031-9155\/42\/10\/010","article-title":"Simultaneous PET and MR imaging","volume":"42","author":"Shao","year":"1997","journal-title":"Phys. Med. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.ejrad.2021.110017_b0350","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.2967\/jnumed.108.045880","article-title":"Latest advances in molecular imaging instrumentation","volume":"49","author":"Pichler","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cpet.2015.09.001","article-title":"Advances in Clinical PET\/MRI Instrumentation","volume":"11","author":"Herzog","year":"2016","journal-title":"PET Clin."},{"key":"10.1016\/j.ejrad.2021.110017_b0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/bmb\/ldt032","article-title":"PET\/MRI: a new technology in the field of molecular imaging","volume":"108","author":"Afaq","year":"2013","journal-title":"Br. Med. Bull."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0365","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neuroimage.2009.10.036","article-title":"The current state, challenges and perspectives of MR-PET","volume":"49","author":"Herzog","year":"2010","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.ejrad.2021.110017_b0370","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.2967\/jnumed.112.105346","article-title":"PET\/MRI for neurologic applications","volume":"53","author":"Catana","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110017_b0375","first-page":"459","article-title":"A pilot study in epilepsy patients using simultaneous PET\/MR","volume":"4","author":"Ding","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00259-015-3201-8","article-title":"High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET\/MR imaging","volume":"43","author":"Hyafil","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.ejrad.2021.110017_b0385","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1007\/s00330-012-2543-x","article-title":"Multimodal imaging utilising integrated MR-PET for human brain tumour assessment","volume":"22","author":"Neuner","year":"2012","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2021.110017_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2015.06.010","article-title":"Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy","volume":"31","author":"Shin","year":"2015","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0395","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/0971-3026.169449","article-title":"Integrated (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging ((18)F-FDG PET\/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay","volume":"25","author":"Jena","year":"2015","journal-title":"Indian J. Radiol. Imaging"},{"issue":"12","key":"10.1016\/j.ejrad.2021.110017_b0400","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00259-016-3462-x","article-title":"Feasibility and acceptance of simultaneous amyloid PET\/MRI","volume":"43","author":"Sch\u00fctz","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.ejrad.2021.110017_b0405","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1097\/RLU.0b013e31829b9e5f","article-title":"Amyloid PET\/MRI in the differential diagnosis of dementia","volume":"39","author":"Vercher-Conejero","year":"2014","journal-title":"Clin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0410","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JAD-150151","article-title":"Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series","volume":"46","author":"Moodley","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.ejrad.2021.110017_b0415","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2967\/jnumed.110.076182","article-title":"Substructural hippocampal glucose metabolism observed on PET\/MRI","volume":"51","author":"Cho","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0420","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2967\/jnumed.110.081281","article-title":"Observation of glucose metabolism in the thalamic nuclei by fusion PET\/MRI","volume":"52","author":"Cho","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"19","key":"10.1016\/j.ejrad.2021.110017_b0425","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1212\/WNL.0000000000001575","article-title":"The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease","volume":"84","author":"Tahmasian","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0430","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2967\/jnumed.115.165464","article-title":"Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET\/MR Study","volume":"57","author":"Tahmasian","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0435","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3233\/JAD-141074","article-title":"Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia","volume":"43","author":"Castellano","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0440","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cpet.2016.05.003","article-title":"Clinical PET\/MR Imaging in Dementia and Neuro-Oncology","volume":"11","author":"Henriksen","year":"2016","journal-title":"PET Clin."},{"issue":"3","key":"10.1016\/j.ejrad.2021.110017_b0445","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3233\/JAD-150163","article-title":"Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject","volume":"47","author":"Tiepolt","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110017_b0450","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2967\/jnumed.114.146787","article-title":"Motion correction strategies for integrated PET\/MR","volume":"56","author":"F\u00fcrst","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110017_b0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13550-016-0200-0","article-title":"Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET\/MRI","volume":"6","author":"Werner","year":"2016","journal-title":"EJNMMI Res."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110017_b0460","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2967\/jnumed.115.163550","article-title":"MRI-Based Attenuation Correction for PET\/MRI Using Multiphase Level-Set Method","volume":"57","author":"An","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.ejrad.2021.110017_b0465","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejrad.2014.04.008","article-title":"Reliability of semiquantitative 18F-FDG PET parameters derived from simultaneous brain PET\/MRI: a feasibility study","volume":"83","author":"Jena","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2021.110017_b0470","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2967\/jnumed.113.126813","article-title":"Systematic Comparison of the Performance of Integrated Whole-Body PET\/MR Imaging to Conventional PET\/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia","volume":"55","author":"Hitz","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.ejrad.2021.110017_b0475","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s00259-016-3394-5","article-title":"Comparison between MRI-based attenuation correction methods for brain PET in dementia patients","volume":"43","author":"Cabello","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21004988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21004988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:27:07Z","timestamp":1759994827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X21004988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":95,"alternative-id":["S0720048X21004988"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110017","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Positron Emission Tomography\/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110017"}}